White House to announce drug pricing deal with Regeneron, source says
23/04/2026 16:45
WASHINGTON, April 23 (Reuters) - The White House will announce a drug pricing deal with pharmaceutical company Regeneron REGN.O on Thursday, according to a source familiar with the matter. (Reporting by Trevor Hunnicutt; Writing by Ryan Patrick Jones; Editing by Susan Heavey) ((ryan.jones@thomsonreuters.com; +1 437 242 1761))
Recent news on Regeneron Pharmaceuticals
See all newsLilly, Regeneron selected for US program to review new manufacturing plants faster (updated)
FDA selects Lilly, Regeneron for program to speed up review of new manufacturing facilities, CNBC reports
Brief: Eli Lilly, Regeneron Among First Companies Selected For FDA Initiative To Speed Review Of New Manufacturing Facilities - CNBC
Brief: Cemdisiran Regulatory Submissions Accepted For Review By FDA And EMA For The Treatment Of Generalized Myasthenia Gravis (Gmg)
AbbVie sharpens immunology focus with $10.9 billion Apogee deal (updated)